Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01450072 · ClinicalTrials.gov registry record · NA
Prospective Randomized Endovascular Therapy in Multiple Sclerosis - PREMiSE
A NA study, sponsored by State University of New York at Buffalo.
- Completed
- Registry status
- NA
- Development phase
- 20
- Enrollment target
NCT01450072 is a NA study that has completed, run by State University of New York at Buffalo. The registered enrollment target is 20 participants.
The verdict
NCT01450072, a NA study, has completed, sponsored by State University of New York at Buffalo.
- COMPLETED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
Study Summary
The Departments of Neurology and Neurosurgery are conducting this research study to evaluate the safety and effectiveness of intravascular angioplasty for the treatment of venous narrowing in the treatment of Multiple Sclerosis (MS).
Interventions
- DEVICE Selective Venography followed by therapeutic balloon angioplasty
- OTHER Control arm
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2010-06 |
| Est. Completion | 2012-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01450072
The ClinicalTrials.gov registry entry for NCT01450072 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is State University of New York at Buffalo, which has 243 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Selective Venography followed by therapeutic balloon angioplasty is the first listed.
NCT01450072 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01450072 about?
NCT01450072 is a clinical study titled "Prospective Randomized Endovascular Therapy in Multiple Sclerosis - PREMiSE". The Departments of Neurology and Neurosurgery are conducting this research study to evaluate the safety and effectiveness of intravascular angioplasty for the treatment of venous narrowing in the treatment of Multiple Sclerosis (MS).
What is the current status of trial NCT01450072?
This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2010-06. Estimated completion is 2012-12.
What interventions are being tested in trial NCT01450072?
The interventions under investigation include: Selective Venography followed by therapeutic balloon angioplasty (DEVICE), Control arm (OTHER).
Who is sponsoring clinical trial NCT01450072?
This trial is sponsored by State University of New York at Buffalo, which has 243 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.